Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients

Clinical trial NCT00631189 · COMPLETED

Trial details

NCT number: NCT00631189
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type IIa and IIb Hypercholesterolaemia

Start date: 2007-10-01
Primary completion: 2008-10-01
Enrollment: 668

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.